BSESpeciality Medicines LtdMediumNeutral
Announced Tue, 28 Apr · 16:30 IST

We hereby inform that the board in its meeting held on April 28, 2026 has approved (1) Appointment of M/s. Hardik Jetani & Associates as secretarial Auditor of the Company for the Financial ....

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.0%1-day move
₹363.05
prior close
₹381.20
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-9.0-13.5-9.2-12.9-8.6-39.4-38.9-45.2
Up moveDown movePending
AI summary

Speciality Medicines Limited held a board meeting on April 28, 2026 where four key items were approved. The company appointed M/s. Hardik Jetani & Associates as Secretarial Auditor for FY 2025-26 and M/s. Rahul Mistri and Co. as Internal Auditor for three financial years (2025-26 to 2027-28). The board also authorized Key Managerial Personnel to determine materiality of events under SEBI Listing Regulations. Additionally, the Audit Committee recommendations on related party transactions were reviewed and acknowledged. Parthkumar Goyani serves as Chairman and Managing Director.

Likely market impact

This is routine governance activity with neutral impact on shareholders. Appointment of external auditors strengthens internal controls and compliance frameworks, which is a positive governance step. No changes to leadership or ownership structure.